NEIL STAHL - EVP Research and Development at REGENERON PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP Research and Development
Issuer Symbol
REGN on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by NEIL STAHL since 04 Jan 2025

Holdings reported by NEIL STAHL for REGENERON PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 48,829 $35,684,721 $730.81 16 Dec 2024 Direct
Common Stock 5,849 $4,274,508 $730.81 16 Dec 2024 By 401(k) Plan
Common Stock 4,605 $3,365,380 $730.81 16 Dec 2024 by Spouse as Trustee
Non-Qualified Stock Option (right to buy) 45,000 02 Aug 2024 Direct Common Stock
Non-Qualified Stock Option (right to buy) 0 02 Feb 2024 Direct Common Stock

Transactions reported by NEIL STAHL for REGENERON PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.